Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Supports energy production and faster recovery
TB-500: The 2026 Recovery Peptide Comparison FDA update July 2026: An FDA advisory panel voted July 2324 to recommend adding BPC-157 and TB-500 to the federal 503A compounding list the strongest regulatory signal yet for the compound, though final FDA rulemaking is still ahead
TB-500 (Thymosin Beta-4 active region) works through actin polymerization and cell migration for systemic tissue remodeling
This precautionary approach protects against unknown risks but eliminates access to compounds some patients credit with life-changing improvements
US$ 28.02
US$ 21.66
US$ 23.87
